All In MedTech

Device Trial Radar · NCT04754477

Long Term Clinical Investigation to Evaluate Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System

A Multicentre, Open, Long-term Clinical Investigation Evaluating Safety, Performance and Patient Reported Outcomes With an Active Osseointegrated Steady-State Implant System in Adult Subjects With Conductive Hearing Loss, Mixed Hearing Loss or Single-sided Sensorineural Deafness.

Last checked: Nov 20, 2026Latest source record: Jun 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

20

Actual

Start

May 6, 2021

Primary completion

Mar 21, 2022

Study completion Mar 21, 2022

Sponsor

Lead sponsor
CochlearNot on our public-company list
Sponsor type
Industry
Collaborators
Statistiska Konsultgruppen
First posted
Feb 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this clinical investigation is to collect long-term safety and performance data with the Active Osseointegrated Steady-State Implant System by following subjects from the previous Osia clinical investigation CBAS5751. In addition, questions regarding device satisfaction, sound satisfaction, usability and health care utilisation will be asked.

Conditions

  • Hearing Loss

Interventions

  • Active Osseointegrated Steady-State Implant System (OSI)Device

    System includes the OSI200 implant surgically placed under the skin behind the ear, the BI300 implant osseointegrated in the bone and the external Osia 2 sound process

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and Type of Reported Adverse EventsTime frame: 6 months post-surgery to 24 months post-surgery

5 more outcomes with a free account

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • SCIC / NextSense

    Gladesville, New South Wales, Australia

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.